New high blood pressure drug shows early promise in small study
Disease control
Terminated
This early-stage study tested a single injection of a new drug called ART101 in adults with high blood pressure. The main goal was to check if the drug is safe and how the body handles it. Only one person took part before the study was stopped, so results are very limited.
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC